PEG-ASP, etoposide and gemcitabine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PEG-ASP, etoposide and gemcitabine, covering 2023-06-18 to 2023-06-18. Get the full timeline:
Most recent: Clinical Trial Update: PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T Lymphoma [Phase 2]